BR9106159A - Polipeptideo sintetico,vacina,estojo para detectar hiv ou anticorpos contra hiv,molecula de dna,composicao farmaceutica,anticorpo ou fragmento de ligacao de antigeno do mesmo,processos de terapia ou profilaxia de infeccao hiv,de detectar hiv,de diagnosticar infeccao hiv e para a manufatura de um polipeptideo sintetico,de uma composicao farmaceutica e de um anticorpo ou fragmento de ligacao do mesmo - Google Patents
Polipeptideo sintetico,vacina,estojo para detectar hiv ou anticorpos contra hiv,molecula de dna,composicao farmaceutica,anticorpo ou fragmento de ligacao de antigeno do mesmo,processos de terapia ou profilaxia de infeccao hiv,de detectar hiv,de diagnosticar infeccao hiv e para a manufatura de um polipeptideo sintetico,de uma composicao farmaceutica e de um anticorpo ou fragmento de ligacao do mesmoInfo
- Publication number
- BR9106159A BR9106159A BR919106159A BR9106159A BR9106159A BR 9106159 A BR9106159 A BR 9106159A BR 919106159 A BR919106159 A BR 919106159A BR 9106159 A BR9106159 A BR 9106159A BR 9106159 A BR9106159 A BR 9106159A
- Authority
- BR
- Brazil
- Prior art keywords
- hiv
- antibody
- pharmaceutical composition
- protecting
- synthetic polypeptide
- Prior art date
Links
- 208000031886 HIV Infections Diseases 0.000 title 2
- 208000037357 HIV infectious disease Diseases 0.000 title 2
- 239000012634 fragment Substances 0.000 title 2
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 title 2
- 239000008194 pharmaceutical composition Substances 0.000 title 2
- 229920001184 polypeptide Polymers 0.000 title 2
- 102000004196 processed proteins & peptides Human genes 0.000 title 2
- 108090000765 processed proteins & peptides Proteins 0.000 title 2
- 108020004414 DNA Proteins 0.000 title 1
- 102000053602 DNA Human genes 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- AIDS & HIV (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909005829A GB9005829D0 (en) | 1990-03-15 | 1990-03-15 | Synthetic polypeptides |
PCT/GB1991/000392 WO1991013909A1 (en) | 1990-03-15 | 1991-03-13 | Synthetic polypeptides |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9106159A true BR9106159A (pt) | 1993-03-16 |
Family
ID=10672665
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR919106159A BR9106159A (pt) | 1990-03-15 | 1991-03-13 | Polipeptideo sintetico,vacina,estojo para detectar hiv ou anticorpos contra hiv,molecula de dna,composicao farmaceutica,anticorpo ou fragmento de ligacao de antigeno do mesmo,processos de terapia ou profilaxia de infeccao hiv,de detectar hiv,de diagnosticar infeccao hiv e para a manufatura de um polipeptideo sintetico,de uma composicao farmaceutica e de um anticorpo ou fragmento de ligacao do mesmo |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0519986A1 (pt) |
JP (1) | JPH05505188A (pt) |
CN (1) | CN1054772A (pt) |
AP (1) | AP211A (pt) |
AU (1) | AU636735B2 (pt) |
BR (1) | BR9106159A (pt) |
CA (1) | CA2078220A1 (pt) |
CS (1) | CS68091A2 (pt) |
FI (1) | FI923800A0 (pt) |
GB (1) | GB9005829D0 (pt) |
HU (1) | HUT63179A (pt) |
IL (1) | IL97551A0 (pt) |
MX (1) | MX24890A (pt) |
NZ (1) | NZ237417A (pt) |
OA (1) | OA09671A (pt) |
WO (1) | WO1991013909A1 (pt) |
ZA (1) | ZA911886B (pt) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU657590B2 (en) * | 1991-11-04 | 1995-03-16 | Dade International Inc. | Synthetic peptides corresponding to portions of HIV-2 virus and methods of using in an improved assay |
US5395750A (en) * | 1992-02-28 | 1995-03-07 | Hoffmann-La Roche Inc. | Methods for producing proteins which bind to predetermined antigens |
US6071895A (en) * | 1992-03-11 | 2000-06-06 | Narhex Limited | Polar-substituted hydrocarbons |
US5888992A (en) * | 1992-03-11 | 1999-03-30 | Narhex Limited | Polar substituted hydrocarbons |
ATE253050T1 (de) | 1992-03-11 | 2003-11-15 | Narhex Ltd | Aminderivate von oxo- und hydroxy- substituierten kohlenwasserstoffen |
RU2126794C1 (ru) * | 1992-03-11 | 1999-02-27 | Нархекс Лимитед | Аминопроизводные оксо- или гидроксизамещенных гидразинов, способ их получения и фармацевтические композиции для ингибирования ретровирусной протеазы |
GB9208428D0 (en) * | 1992-04-16 | 1992-06-03 | Proteus Molecular Design | Synthetic polypeptides |
US6511845B1 (en) | 1992-08-07 | 2003-01-28 | Alan R. Davis | Methods for producing an immune response against HIV-1 |
US6261569B1 (en) | 1992-08-27 | 2001-07-17 | Deakin Research Limited | Retro-, inverso- and retro-inverso synthetic peptide analogues |
DE4402756A1 (de) * | 1994-01-31 | 1995-08-03 | Boehringer Mannheim Gmbh | Spezifische Bindungssubstanzen für Antikörper und deren Verwendung für Immunoassays oder Vakzine |
AUPM411994A0 (en) * | 1994-02-25 | 1994-03-24 | Deakin Research Limited | Epitopes |
US6764682B1 (en) * | 1994-06-16 | 2004-07-20 | Aventis Pasteur Limited | Adjuvant compositions containing more than one adjuvant |
US6290971B1 (en) | 1995-06-15 | 2001-09-18 | Aventis Pasteur Limited | Adjuvant compositions comprising a mineral salt and another immunostimulating compound |
CN1472314A (zh) * | 2002-07-29 | 2004-02-04 | 清华大学 | 艾滋病病毒o型株的一个免疫学表位及其应用 |
CN100445296C (zh) * | 2006-03-31 | 2008-12-24 | 浙江大学 | 多肽有机化合物及其在异种移植中的应用 |
WO2010057197A1 (en) | 2008-11-17 | 2010-05-20 | The Regents Of The University Of Michigan | Cancer vaccine compositions and methods of using the same |
GB201612108D0 (en) | 2016-07-12 | 2016-08-24 | Univ Strathclyde | Preperation of non-ionic surfactant vesicles and variants |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8714802D0 (en) * | 1987-06-24 | 1987-07-29 | Proteus Biotech Ltd | Synthetic polypeptides |
DE3879881D1 (de) * | 1987-11-16 | 1993-05-06 | Hoffmann La Roche | Rekombinante hiv-2 polypeptide. |
-
1990
- 1990-03-15 GB GB909005829A patent/GB9005829D0/en active Pending
-
1991
- 1991-03-13 AU AU74679/91A patent/AU636735B2/en not_active Ceased
- 1991-03-13 BR BR919106159A patent/BR9106159A/pt not_active Application Discontinuation
- 1991-03-13 WO PCT/GB1991/000392 patent/WO1991013909A1/en not_active Application Discontinuation
- 1991-03-13 HU HU922939A patent/HUT63179A/hu unknown
- 1991-03-13 CA CA002078220A patent/CA2078220A1/en not_active Abandoned
- 1991-03-13 JP JP3505817A patent/JPH05505188A/ja active Pending
- 1991-03-13 EP EP91906077A patent/EP0519986A1/en not_active Withdrawn
- 1991-03-13 NZ NZ237417A patent/NZ237417A/en unknown
- 1991-03-13 MX MX2489091A patent/MX24890A/es unknown
- 1991-03-14 ZA ZA911886A patent/ZA911886B/xx unknown
- 1991-03-14 AP APAP/P/1991/000245A patent/AP211A/en active
- 1991-03-14 IL IL97551A patent/IL97551A0/xx unknown
- 1991-03-15 CS CS91680A patent/CS68091A2/cs unknown
- 1991-03-15 CN CN91101549A patent/CN1054772A/zh active Pending
-
1992
- 1992-08-24 FI FI923800A patent/FI923800A0/fi not_active Application Discontinuation
- 1992-09-11 OA OA60275A patent/OA09671A/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU7467991A (en) | 1991-10-10 |
WO1991013909A1 (en) | 1991-09-19 |
CS68091A2 (en) | 1991-12-17 |
HU9202939D0 (en) | 1992-12-28 |
FI923800A (fi) | 1992-08-24 |
MX24890A (es) | 1993-12-01 |
AP211A (en) | 1992-10-21 |
AP9100245A0 (en) | 1991-04-30 |
HUT63179A (en) | 1993-07-28 |
GB9005829D0 (en) | 1990-05-09 |
OA09671A (en) | 1993-05-15 |
EP0519986A1 (en) | 1992-12-30 |
CN1054772A (zh) | 1991-09-25 |
CA2078220A1 (en) | 1991-09-16 |
JPH05505188A (ja) | 1993-08-05 |
FI923800A0 (fi) | 1992-08-24 |
ZA911886B (en) | 1991-12-24 |
AU636735B2 (en) | 1993-05-06 |
IL97551A0 (en) | 1992-06-21 |
NZ237417A (en) | 1993-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9106159A (pt) | Polipeptideo sintetico,vacina,estojo para detectar hiv ou anticorpos contra hiv,molecula de dna,composicao farmaceutica,anticorpo ou fragmento de ligacao de antigeno do mesmo,processos de terapia ou profilaxia de infeccao hiv,de detectar hiv,de diagnosticar infeccao hiv e para a manufatura de um polipeptideo sintetico,de uma composicao farmaceutica e de um anticorpo ou fragmento de ligacao do mesmo | |
MX9202875A (es) | Una molecula de dna recombinante y procedimiento para su obtencion. | |
PT90731A (pt) | Processo para a preparacao de uma molecula de adn recombinante, de vacina para proteccao contra hiv e de diagnostico de exposicao a hiv | |
BR8703552A (pt) | Processo para preparar peptidio,peptidio antigenico,anticorpos imunoespecificos,peptidio,processo para avaliacao da presenca do hpv em uma amostra,processo para protecao de uma materia em oposicao a infeccao de hpv,processo para avaliacao de estagio da infeccao por hpv em biopsias ou esfregacos cervicais e processo para imunoterapia passiva contra a infeccao por hpv | |
NZ503763A (en) | Antigenic compositions and vaccines comprising a high molecular weight (HMW) protein of Clamydia for therapeutic and prophylactic use | |
DK614987A (da) | Syntetiske htlv-iii peptider, praeparater og anvendelser deraf | |
BR8701528A (pt) | Proteina,sequencia de dna,vetor recombinante,organismo celular,processos para producao de uma proteina e para a preparacao de um organismo unicelular,processos para a deteccao da presenca de anticorpos e de virus de aids,processos para a preparacao de uma vacina e para a preparacao de anticorpos,formulacao de vacina,anticorpos,uso,vacina,kit de teste e metodo para a prevencao de aids | |
BR8906988A (pt) | Tetrapiptidio,peptidio,composicao farmaceutica,processo para uso de peptidio e reagente para diagnostico | |
BR9711457A (pt) | Compostos e processo para o tratamento e diagnóstico de infecções micobacterianas. | |
EP0090581A3 (en) | Small peptides with the specificity of foot and mouth disease viral antigens | |
KR890002547A (ko) | Hiv 감염의 치료 및 진단용 모노클로날항체 및 펩티드 | |
BR9709958A (pt) | Polipeptídeos capaz de formar estruturas de ligaçãode antígeno com especificidade para os antígenos de rhesus d o dna que os codifica e o processo para sua preparação e uso | |
ES2137310T3 (es) | Vacuna contra una infeccion por streptococcus suis. | |
ATE429248T1 (de) | Verwendung cd28 spezifischer monoklonaler antikörper zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von virusinfektionen | |
DE59508137D1 (de) | Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine | |
ATE164311T1 (de) | Orale, pharmazeutische zusammensetzungen das ein protein oder peptide, eine antikoerper und polymerkugeln enthalten | |
RU94045907A (ru) | Вич-антитела человека или их фрагменты, экспрессионные кассеты, клетки-хозяева, фармацевтические композиции, способ защиты | |
BR9404004A (pt) | Poliptídeo isolado fragmento antigênico parte derivado ou análogo molécula de ácido nucléico método para reduzir o alastramento de um parasita helmíntico e composição de vacina | |
ATE109158T1 (de) | Rubella-e1 und c peptide. | |
EP0293827A3 (en) | Assay for leishmaniasis | |
ATE176913T1 (de) | Faser-hemagglutinin von b. pertussis | |
ATE134878T1 (de) | Impfstoffe gegen metazoen-parasiten | |
FR2694938B1 (fr) | Nouveaux peptides, anticorps diriges contre ces peptides, anticorps anti-idiotypiques, application a titre de medicaments, compositions pharmaceutiques et kits de diagnostic les renfermant. | |
ATE366583T1 (de) | Identifizierung von spezifischen differenziell exprimierten antigenen aus mycobacterium und medizinische verwendung der mycobakteriumproteine rv0068 und rv3407 | |
DE69433057D1 (de) | Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EG | Technical examination (opinion): publication of technical examination (opinion) | ||
FC | Decision: refusal | ||
B15K | Others concerning applications: alteration of classification |
Ipc: C07K 14/005 (2006.01), C07K 16/10 (2006.0 |